Search Results - "Fuentes Jiménez, Francisco"

Statins in Non-alcoholic Steatohepatitis by Torres-Peña, Jose D, Martín-Piedra, Laura, Fuentes-Jiménez, Francisco

“…Non-alcoholic fatty liver disease (NAFLD) is the primary cause of chronic liver disease. The range is extensive, including hepatocellular carcinoma, cirrhosis,…”
Get full text

Validation of a non-invasive method for the early detection of metabolic syndrome: a diagnostic accuracy test in a working population by Romero-Saldaña, Manuel, Tauler, Pedro, Vaquero-Abellán, Manuel, López-González, Angel-Arturo, Fuentes-Jiménez, Francisco-José, Aguiló, Antoni, Álvarez-Fernández, Carlos, Molina-Recio, Guillermo, Bennasar-Veny, Miquel

“…ObjectivesA non-invasive method for the early detection of metabolic syndrome (NIM-MetS) using only waist-to-height ratio (WHtR) and blood pressure (BP) has…”
Get full text

Clinical and Molecular Characteristics of Homozygous Familial Hypercholesterolemia Patients: Insights from SAFEHEART Registry by Alonso, Rodrigo, MD, PhD, Díaz-Díaz, Jose Luis, MD, PhD, Arrieta, Francisco, MD, Fuentes-Jiménez, Francisco, MD, PhD, de Andrés, Raimundo, MD, PhD, Saenz, Pedro, MD, PhD, Ariceta, Gema, MD, Vidal-Pardo, José I., MD, PhD, Almagro, Fatima, MD, PhD, Argueso, Rosa, MD, Prieto-Matos, Pablo, MD, Miramontes, José P., MD, PhD, Pintó, Xavier, MD, PhD, Rodriguez-Urrego, Johana, MD, Perez de Isla, Leopoldo, MD, PhD, Mata, Pedro, MD, PhD

“…Abstract Background Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder associated with very high levels of cholesterol, accelerated…”
Get full text

Lipoprotein(a) Levels in Familial Hypercholesterolemia: An Important Predictor of Cardiovascular Disease Independent of the Type of LDL Receptor Mutation by ALONSO, Rodrigo, ANDRES, Eduardo, ORDOVAS, Jose María, MATA, Pedro, MATA, Nelva, FUENTES-JIMENEZ, Francisco, BADIMON, Lina, LOPEZ-MIRANDA, José, PADRO, Teresa, MUNIZ, Ovidio, DIAZ-DIAZ, Jose Luis, MAURI, Marta

“…The aim of this study was to determine the relationship between lipoprotein(a) [Lp(a)] and cardiovascular disease (CVD) in a large cohort of patients with…”
Get full text

Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study) by Pérez de Isla, Leopoldo, Alonso, Rodrigo, Mata, Nelva, Fernández-Pérez, Cristina, Muñiz, Ovidio, Díaz-Díaz, José Luis, Saltijeral, Adriana, Fuentes-Jiménez, Francisco, de Andrés, Raimundo, Zambón, Daniel, Piedecausa, Mar, Cepeda, José María, Mauri, Marta, Galiana, Jesús, Brea, Ángel, Sanchez Muñoz-Torrero, Juan Francisco, Padró, Teresa, Argueso, Rosa, Miramontes-González, José Pablo, Badimón, Lina, Santos, Raúl D, Watts, Gerald F, Mata, Pedro

“…BACKGROUND:Although risk factors for atherosclerotic cardiovascular disease (ASCVD) in familial hypercholesterolemia (FH) have been described, models for…”
Get full text

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study by Pérez-Belmonte, Luis M, Torres-Peña, José David, López-Carmona, María D, Ayala-Gutiérrez, M Mar, Fuentes-Jiménez, Francisco, Huerta, Lucía Jorge, Muñoz, Jaime Alonso, Rubio-Rivas, Manuel, Madrazo, Manel, Garcia, Marcos Guzmán, Montes, Beatriz Vicente, Sola, Joaquim Fernández, Ena, Javier, Ferrer, Ruth Gonzalez, Pérez, Carmen Mella, Ripper, Carlos Jorge, Lecumberri, Jose Javier Napal, Acedo, Iris El Attar, Canteli, Susana Plaza, Cosío, Sara Fuente, Martínez, Francisco Amorós, Rodríguez, Begoña Cortés, Pérez-Martínez, Pablo, Ramos-Rincón, José Manuel, Gómez-Huelgas, Ricardo

“…Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital…”
Get full text

Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study by Alonso, Rodrigo, Arroyo-Olivares, Raquel, Díaz-Díaz, Jose Luis, Fuentes-Jiménez, Francisco, Arrieta, Francisco, de Andrés, Raimundo, Gonzalez-Bustos, Pablo, Argueso, Rosa, Martin-Ordiales, Mercedes, Martinez-Faedo, Ceferino, Illán, Fátima, Saenz, Pedro, Donate, José María, Sanchez Muñoz-Torrero, Juan F., Martinez-Hervas, Sergio, Mata, Pedro

“…We aimed to describe clinical and genetic characteristics, lipid-lowering treatment and atherosclerotic cardiovascular disease (ASCVD) outcomes over a…”
Get full text

Design and Validity of a Choice-Modeling Questionnaire to Analyze the Feasibility of Implementing Physical Activity on Prescription at Primary Health-Care Settings by Calonge-Pascual, Sergio, Fuentes-Jiménez, Francisco, Casajús Mallén, José A, González-Gross, Marcela

“…Worldwide health policies are trying to implement physical activity on prescription (PAP) at healthcare settings. However, there is not a proper methodology to…”
Get full text

Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study by Alonso, Rodrigo, Arroyo-Olivares, Raquel, Muñiz-Grijalvo, Ovidio, Díaz-Díaz, Jose Luis, Muñoz-Torrero, Juan Sanchez, Romero, Manuel J, de Andrés, Raimundo, Zambón, Daniel, Mañas, María Dolores, Fuentes-Jiménez, Francisco, Aguado, Rocío, Alvarez-Baños, Pilar, Arrieta, Francisco, Gonzalez-Bustos, Pablo, Cepeda, José, Martin-Ordiales, Mercedes, Mosquera, Daniel, Michan, Alfredo, de Isla, Leopoldo Perez, Argueso, Rosa, Mata, Pedro

“…Most heterozygous familial hypercholesterolaemia (FH) patients require intensive lipid-lowering therapy (LLT) including PCSK9 inhibitors (PCSK9is) to reach…”
Get full text

Adults with familial hypercholesterolaemia have healthier dietary and lifestyle habits compared with their non-affected relatives: the SAFEHEART study by Arroyo-Olivares, Raquel, Alonso, Rodrigo, Quintana-Navarro, Gracia, Fuentes-Jiménez, Francisco, Mata, Nelva, Muñiz-Grijalvo, Ovidio, Díaz-Díaz, José L, Zambón, Daniel, Arrieta, Francisco, García-Cruces, Jesús, Garrido-Sanjuan, Juan A, Banegas, José R, Mata, Pedro

“…Healthy lifestyle habits are the cornerstone in the management of familial hypercholesterolaemia (FH). Nevertheless, dietary studies on FH-affected populations…”
Get full text

Moderate-to-high-intensity training and a hypocaloric Mediterranean diet enhance endothelial progenitor cells and fitness in subjects with the metabolic syndrome by Fernández, Juan Marcelo, Rosado-Álvarez, Daniel, Da Silva Grigoletto, Marzo Edir, Rangel-Zúñiga, Oriol Alberto, Landaeta-Díaz, Leslie Lorena, Caballero-Villarraso, Javier, López-Miranda, José, Pérez-Jiménez, Francisco, Fuentes-Jiménez, Francisco

“…A reduction in EPC (endothelial progenitor cell) number could explain the development and progression of atherosclerosis in the MetS (metabolic syndrome)…”
Get more information

Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes by Alonso, Rodrigo, Mata, Pedro, Zambón, Daniel, Mata, Nelva, Fuentes-Jiménez, Francisco

“…Familial hypercholesterolemia (FH) is the most frequent inherited disorder associated with premature coronary artery disease. Early identification and…”
Get more information

Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis by Perez-Martinez, Pablo, Alcala-Diaz, Juan F., Delgado-Lista, Javier, Garcia-Rios, Antonio, Gomez-Delgado, Francisco, Marin-Hinojosa, Carmen, Rodriguez-Cantalejo, Fernando, Delgado-Casado, Nieves, Perez-Caballero, Ana I., Fuentes-Jimenez, Francisco J., Camargo, Antonio, Tinahones, Francisco J., Ordovas, Jose M., Perez-Jimenez, Francisco, Lopez-Miranda, Jose

“…Background We examined the degree of postprandial triglyceride (TG) response over the day, representing a highly dynamic state, with continuous metabolic…”
Get full text

Influence of Obesity and Metabolic Disease on Carotid Atherosclerosis in Patients with Coronary Artery Disease (CordioPrev Study) by Talavera-Garcia, Eva, Delgado-Lista, Javier, Garcia-Rios, Antonio, Delgado-Casado, Nieves, Gomez-Luna, Purificacion, Gomez-Garduño, Angela, Gomez-Delgado, Francisco, Alcala-Diaz, Juan F, Yubero-Serrano, Elena, Marin, Carmen, Perez-Caballero, Ana I, Fuentes-Jimenez, Francisco J, Camargo, Antonio, Rodriguez-Cantalejo, Fernando, Tinahones, Francisco J, Ordovas, Jose M, Perez-Jimenez, Francisco, Perez-Martinez, Pablo, Lopez-Miranda, Jose

“…Recent data suggest that the presence of associated metabolic abnormalities may be important modifiers of the association of obesity with a poorer prognosis in…”
Get full text

New non-invasive method for early detection of metabolic syndrome in the working population by Romero-Saldaña, Manuel, Fuentes-Jiménez, Francisco J, Vaquero-Abellán, Manuel, Álvarez-Fernández, Carlos, Molina-Recio, Guillermo, López-Miranda, José

“…Background: We propose a new method for the early detection of metabolic syndrome in the working population, which was free of biomarkers (non-invasive) and…”
Get full text

Predictive Capacity and Cutoff Value of Waist-to-Height Ratio in the Incidence of Metabolic Syndrome by Romero-Saldaña, Manuel, Fuentes-Jiménez, Francisco J., Vaquero-Abellán, Manuel, Álvarez-Fernández, Carlos, Aguilera-López, María Dolores, Molina-Recio, Guillermo

“…The purpose of this study was to compare the predictive ability of waist-to-height ratio (WHtR) compared with other anthropometric indicators in the incidence…”
Get full text

Diagnosis and treatment of familial hypercholesterolemia in Spain: consensus document by Mata, Pedro, Alonso, Rodrigo, Ruiz, Antonio, Gonzalez-Juanatey, Jose R, Badimón, Lina, Díaz-Díaz, Jose L, Muñoz, María Teresa, Muñiz, Ovidio, Galve, Enrique, Irigoyen, Luis, Fuentes-Jiménez, Francisco, Dalmau, Jaime, Pérez-Jiménez, Francisco

“…Familial hypercholesterolemia (FH) is a common genetic disorder, clinically manifested since birth, and associated with very high levels of plasma…”
Get full text

NOS3 Glu298Asp Polymorphism Interacts with Virgin Olive Oil Phenols to Determine the Postprandial Endothelial Function in Patients with the Metabolic Syndrome by Jiménez-Morales, Ana I, Ruano, Juan, Delgado-Lista, Javier, Fernandez, Juan M, Camargo, Antonio, López-Segura, Fernando, Villarraso, Javier Caballero, Fuentes-Jiménez, Francisco, López-Miranda, Jose, Pérez-Jiménez, Francisco

“…Background: Glu298Asp polymorphism of the endothelial nitric oxide synthase (eNOS) gene (NOS3) has been characterized as a risk factor of hypertension and…”
Get full text

Correction: Influence of Obesity and Metabolic Disease on Carotid Atherosclerosis in Patients with Coronary Artery Disease (CordioPrev Study) by Talavera-Garcia, Eva, Delgado-Lista, Javier, Garcia-Rios, Antonio, Delgado-Casado, Nieves, Gomez-Luna, Purificacion, Gomez-Garduño, Angela, Gomez-Delgado, Francisco, Alcala-Diaz, Juan F, Yubero-Serrano, Elena, Marin, Carmen, Perez-Caballero, Ana I, Fuentes-Jimenez, Francisco J, Camargo, Antonio, Rodriguez-Cantalejo, Fernando, Tinahones, Francisco J, Ordovas, Jose M, Perez-Jimenez, Francisco, Perez-Martinez, Pablo, Lopez-Miranda, Jose

“…[This corrects the article DOI: 10.1371/journal.pone.0153096.]…”
Get full text

Lipoprotein(a) Levels in Familial Hypercholesterolemia by Alonso, Rodrigo, MD, PhD, Andres, Eduardo, BSc, Mata, Nelva, MD, Fuentes-Jiménez, Francisco, MD, PhD, Badimón, Lina, PhD, López-Miranda, José, MD, PhD, Padró, Teresa, PhD, Muñiz, Ovidio, MD, PhD, Díaz-Díaz, Jose Luis, MD, PhD, Mauri, Marta, MD, Ordovás, Jose María, PhD, Mata, Pedro, MD, PhD

“…Objectives The aim of this study was to determine the relationship between lipoprotein(a) [Lp(a)] and cardiovascular disease (CVD) in a large cohort of…”
Get full text